Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

Immatics & GSK Partner to Develop Adoptive Cell Therapies (2020-02-20)
> GSK to obtain access to two Immatics TCR-T programs, further advancing their commitment to the field of cell therapies > Immatics to receive €45 Million (~$50 Million) upfront payment with potential for additional milestone and royalty payments Immatics B...
CTC North Is Partner in HepB Vaccine H2020 Project TherVacB (2020-02-20)
On 1st January, 2020 a new research project in hepatitis B has started under the European Horizon 2020 programme. The main objective of the TherVacB project is to develop a therapeutic vaccine to cure hepatitis B patients. More than three percent of the world's...
Optibrium: Tim Hohm Director Commercial Strategy & BusDev (2020-02-17)
Tim Hohm to further develop Optibrium’s sales and business strategy for global market expansion Optibrium™, a developer of software for drug discovery, today announced the appointment of Dr Tim Hohm as Director of Commercial Strategy and Business Development...
Edinburgh-based Pheno Therapeutics Raises £5m Series A (2020-02-17)
Novel treatments that may reverse the effects of multiple sclerosis will be investigated by a new drug-discovery company spun out from the University of Edinburgh. Backed by Series A funding of £5 million over its first three years, Pheno Therapeutics will searc...
TrakCel Appoints Fiona Withey as Chief Executive Officer (2020-02-17)
New CEO to guide TrakCel to next phase of growth TrakCel, a leading software developer of orchestration systems for advanced therapies, announced today the appointment of Dr. Fiona Withey as Chief Executive Officer and co-founder Ravi Nalliah to the role of Ch...
Scotland: £9.5m to Compete in Global Precision Medicine (2020-02-17)
Scotland’s Deputy First Minister, John Swinney, has announced up to £9.5 million of new funding to strengthen Scotland’s position in precision medicine, an industry estimated to be worth over $130 billion by 2025. The announcement was made at a gathering of academi...
OMass Therapeutics Raises £27.5m Series A Extension (2020-02-17)
– Developing a pipeline of small molecule therapeutics for patients with immunological and genetic disorders – OMass Therapeutics (“OMass”), a biotechnology company harnessing native mass spectrometry to drive drug discovery in high definition, today announced...
o2h Ventures Makes an Investment in Turbine (2020-02-15)
The o2h Therapeutics and AI Fund (“The Fund”), an early stage S/EIS fund investing in biotechnology therapeutics and related AI opportunities, is pleased to announce an investment in Turbine, a simulation-based drug discovery company. Based on a decade of resear...
o2h Ventures Makes an Investment in Pencil Biosciences (2020-02-15)
The o2h Therapeutics and AI Fund (“The Fund”), an early stage S/EIS fund investing in biotechnology therapeutics and related AI opportunities, is pleased to announce an investment in Pencil Biosciences, a novel gene modulation biotech company based at Alderley Park...
ERS Genomics/Aelian Biotechnology: CRISPR License Agreement (2020-02-11)
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Aelian Biotechnology (“Aelian”) today announced the signing of a license agreement granting Aelian acces...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

Start here with the latest News!

Picture Fairtec GmbH Worldwide Event Solutions 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top